Diagnostic Test to Identify Parkinson’s Disease from the Blood Sera of Chinese Population: A Cross‐Sectional Study
Parkinson's Disease · 2022-01 · 2022 (1)
DOI: 10.1155/2022/8683877 ↗Kurz gefasst
Fachartikel in der Zeitschrift Parkinson's Disease, online erschienen am 06.04.2022. Verfasst von Guangan Tong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei 230031, Anhui, China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anhui Medical University.
Abstract (Originalsprache)
Background
Parkinson’s disease (PD) is a neurodegenerative disease, a hallmark by the formation of misfolded and aggregated α ‐synuclein proteins. The expression of potential microRNA (miRNA) candidates isolated from serum and cerebrospinal fluid (CSF) exosomes of PD patients was assessed for their diagnostic value and their potential role as biomarkers for PD was explored. In this study, we characterize the expression level of miRNAs in the exosomes of blood sera and cerebrospinal fluid and explore their potential role as biomarkers for PD. Materials and Methods . A total of 209 patients having an onset of PD, along with 60 neurodegenerative (ND) disorders and 50 healthy controls were enrolled. Blood samples and CSF samples were collected and exosomes were isolated. The isolated exosomes were characterized using CD63 detection and exosomal RNA was extracted. Serum miRNA profiling was carried out by synthesizing cDNA from the purified RNA and miRNA transcripts were determined by qRT‐PCR using SYBR Green PremixScript. microRNA profiling strategy was employed for extracting the exosomal miRNAs from the exosomes.
Results
Five common miRNAs viz. miR‐151a‐5p, miR‐24, mir‐485‐5p, mir‐331‐5p, and mir‐214 were found to be upregulated with statistical significance in both the serum exosome and CSF exosomes. The investigation revealed that serum and CSF exosomal miRNA molecules are definitive biomarkers for PD with proper specificity and sensitivity.
Conclusions
The significant level of miR‐151a‐5p, miR‐24, mir‐485‐5p, mir‐331‐5p, and mir‐214 was observed in the serum and CSF which may be established as a biomarker for the diagnosis of PD.
Autor:innen und Institutionen
- Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei 230031, Anhui, China.
- The Affiliated Hospital of the Neurology Institute, Anhui University of Chinese Medicine, Hefei 230031, Anhui, China.
- Department of Physiology, School of Basic Medicine, Anhui Medical University, Hefei 230012, Anhui, China.
- Department of Neurology, People's Hospital of Taihe County, Taihe 236600, Anhui, China.
ORCID-Profile: Guangan Tong, Xianwen Chen
Förderung
- Anhui Medical University
Zitieren
APA
Tong, G., Zhang, P., Hu, W., Zhang, K., & Chen, X. (2022). Diagnostic Test to Identify Parkinson’s Disease from the Blood Sera of Chinese Population: A Cross‐Sectional Study. Parkinson's Disease, 2022(1). https://doi.org/10.1155/2022/8683877
Vancouver
Tong G, Zhang P, Hu W, Zhang K, Chen X. Diagnostic Test to Identify Parkinson’s Disease from the Blood Sera of Chinese Population: A Cross‐Sectional Study. Parkinson's Disease. 2022;2022(1). doi:10.1155/2022/8683877
BibTeX
@article{Tong2022,
author = {Tong, Guangan and Zhang, Pingping and Hu, Wenbin and Zhang, Kun and Chen, Xianwen},
title = {Diagnostic Test to Identify Parkinson’s Disease from the Blood Sera of Chinese Population: A Cross‐Sectional Study},
journal = {Parkinson's Disease},
year = {2022},
volume = {2022},
number = {1},
doi = {10.1155/2022/8683877}
}
EUVIMED